Genomics

Dataset Information

0

Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human ChIP-Seq)


ABSTRACT: The nature and the role of global transcriptional deregulations in cancers are not fully understood. We report a phenotype in a significant portion of cancers characterized by widespread defects in mRNA transcription elongation (TE). Cancers with TE defects (TEdeff) were characterized by spurious transcription and defective mRNA processing, specifically in a large set of genes characterized by long genomic length, poised promoters and inducible expression. As such, signaling pathways regulated by such genes, such as interferon/JAK/STAT and TNF/NF-κB pathways, were consistently suppressed in TEdeff tumors. Remarkably, TEdeff significantly correlated with the poor response and outcome in immunotherapy, but not chemo- or targeted therapy, -treated renal cell carcinoma and metastatic melanoma patients in 4 different cohorts. Importantly, forced pharmacologic or genetic induction of TEdeff in tumor cells impaired the expression of the interferon/JAK/STAT and TNF/NF-κB pathways, and imposed resistance to the innate and adaptive anti-tumor immune responses and checkpoint inhibitor therapy in vivo. Therefore, defective TE is a novel epigenetic mechanism in the tumor arsenal of immune resistance tools, which warrants its assessment in cancer patients undergoing immunotherapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119676 | GEO | 2018/09/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-09-08 | GSE119677 | GEO
2018-09-08 | GSE119674 | GEO
2018-09-08 | GSE119678 | GEO
2018-09-08 | GSE119673 | GEO
2015-05-12 | E-GEOD-67346 | biostudies-arrayexpress
2015-05-12 | GSE67346 | GEO
2015-01-30 | GSE63254 | GEO
2014-06-03 | E-GEOD-54645 | biostudies-arrayexpress
2014-06-03 | E-GEOD-54644 | biostudies-arrayexpress
| PRJNA770946 | ENA